Mar 01, 2024 / Comment Letters MedPAC comment on CMS’s advance notice of methodological changes for CY 2025 for Medicare Advantage capitation rates and Part C and D payment policies Research Areas: Private Plans, Quality
Jan 12, 2024 / Transcripts January 2024 meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Jan 11, 2024 / Presentations Medicare Part D: Status report Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing
Jan 05, 2024 / Comment Letters MedPAC comment on CMS’s proposed rule on policy and technical changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program for 2025 Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans
Dec 08, 2023 / Transcripts December 2023 meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Oct 05, 2023 / Presentations Workplan: Prices of generic drugs under Part D Research Areas: Drugs, Devices, and Tests
Jun 15, 2023 / Chapters Executive summary (June 2023 report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jun 15, 2023 / Reports June 2023 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Apr 13, 2023 / Presentations Assessing postsale rebates for prescription drugs in Medicare Part D Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing
Mar 15, 2023 / Reports March 2023 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues